Synlogic, Inc. (SYBX) EPS Estimated At $-0.79

March 16, 2018 - By Ellis Scott

 Synlogic, Inc. (SYBX) EPS Estimated At $ 0.79

Analysts expect Synlogic, Inc. (NASDAQ:SYBX) to report $-0.79 EPS on March, 21.They anticipate $2.15 EPS change or 73.13 % from last quarter’s $-2.94 EPS. After having $-1.66 EPS previously, Synlogic, Inc.’s analysts see -52.41 % EPS growth. The stock increased 0.90% or $0.09 during the last trading session, reaching $10.04. About 89,343 shares traded. Synlogic, Inc. (NASDAQ:SYBX) has 0.00% since March 16, 2017 and is . It has underperformed by 16.70% the S&P500.

Synlogic, Inc. develops synthetic biotic medicines for the treatment of patients with urea cycle disorder and phenylketonuria. The company has market cap of $222.73 million.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.